Pascal Biosciences
Christi Wood is a seasoned scientist with extensive experience in the biopharmaceutical industry. Currently serving as a Staff Scientist at Pascal Biosciences Inc. since 2017, Christi has previously held staff scientist positions at Omeros Corporation from 2011 to 2016, and at ICOS from 1992 to 2007. Prior to these roles, Christi was a Senior Research Associate at XORI Corporation for a year in 2010, and held a similar position at VLST Corp between August 2007 and November 2009.
This person is not in any teams
Pascal Biosciences
Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company’s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system.